A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia is a research paper published in American Journal of Hematology (2020). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: Intramural Research Program
Intramural NIH HHS
Grant: ZIC BC011093
Intramural NIH HHS
Grant: ZIA HL006070
National Institutes of Health
MeSH Terms